#IRDs)
Sev ppl have said to me that the Greens want to tax hardworking ppl. They obv haven't read the IRDs rept on tax. Most ppl r turned off by politics. Even when u pt out most pay a higher tax rate than the rich they shrug. These ppl aren't bottomfeeders. How do u get them to vote to reduce inequality?
November 8, 2026 at 8:56 AM
✨Davide Rozza - gout mortality vs other IRDs, vs CVD and cancer mortality

Ecological study of country level data from WHO mortality data 2000-2023

age/sex SMR, with APCs for trends

#2026GCAN #ACR26
November 5, 2026 at 5:12 PM
Knuckle tats that say GO_B IRDS
November 2, 2026 at 4:04 AM
October 19, 2026 at 11:48 PM
The EMA has opened a consultation for a draft concept paper exploring the need for dedicated guidance on the clinical investigation of medicines intended to treat Inherited Retinal Dystrophies (#IRDs).
Deadline for submissions: 31 January 2027
Read the draft concept paper:
https://ow.ly/KlKY50ZYmg0
October 19, 2026 at 11:00 AM
Ophthopedia Update: Stem Cell Therapy for Inherited Retinal Disorders: Rebuilding the Retina: Inherited retinal disorders (IRDs) are a group of genetically heterogeneous ophthalmic conditions with diverse clinical manifestations,1 which are characterized by… #Ophthalmology #Ophthotwitter #Scicomm
Stem Cell Therapy for Inherited Retinal Disorders: Rebuilding the Retina
Inherited retinal disorders (IRDs) are a group of genetically heterogeneous ophthalmic conditions with diverse clinical manifestations,1 which are characterized by progressive degeneration of photoreceptors and/or the retinal pigment epithelium (RPE). As human photoreceptors do not have the capacity to regenerate, IRDs lead to irreversible vision loss, with no curative therapies available to restore vision. In total, IRDs are estimated to affect approximately 1 in 1400 individuals in the United States,2 highlighting the need for effective therapies.
dlvr.it
October 1, 2026 at 1:25 AM
This Saturday, 3rd October, people living with IRDs will come together for the USHER Austria Patient Symposium 2026: “Where are we now: Updates on Inherited Retinal Diseases – RP, Usher and more.” RI CEO Avril Daly will be joining the programme.

For more information: https://ow.ly/qvLe50ZTqwM
October 1, 2026 at 10:30 AM
Boooooo-irds
September 23, 2026 at 12:34 AM
Νέα φωτογραφία του F-22A Raptor δείχνει δύο εξωτερικά ατρακτίδια stealth στο πλαίσιο των δοκιμών IRST, ενώ το πρόγραμμα IRDS προχωρά με…

#Αεροπορία #Aviation
Η μυστηριώδης «λευκή κοιλιά» και όχι μόνο ενός Raptor - ΠΤΗΣΗ
Νέα εμφάνιση F-22A Raptor με τα υπό δοκιμή εξωτερικά  φερόμενα ατρακτίδια stealth, καταγράφηκε στην Καλιφόρνια, προσφέροντας την καθαρότερη μέχρι σήμερα εικόνα της προσπάθειας να αποκτήσει το αμερικανικό μαχητικό παθητική δυνατότητα εντοπισμού στόχων. Το F-22, με κωδικό κλήση FEVER21, φωτογραφήθηκε στις 19 Σεπτεμβρίου με δύο ατρακτίδια στους εξωτερικούς υποπτερυγικούς σταθμούς. Αυτά έχουν εμφανιστεί σε δοκιμές από […]
flight.com.gr
September 21, 2026 at 4:21 PM
Ophthopedia Update: Visual field and driving performance of individuals with inherited retinal disorders: a scoping review: Objective

Maintaining a drivers’ licence is an important patient-reported outcome. Conditions resulting in peripheral vision loss such as inherited retinal disorders (IRDs)…
Visual field and driving performance of individuals with inherited retinal disorders: a scoping review
Objective Maintaining a drivers’ licence is an important patient-reported outcome. Conditions resulting in peripheral vision loss such as inherited retinal disorders (IRDs) can result in loss of licence due to an inadequate horizontal visual field (VF) extent. There are currently no international visual standards for licensing and current testing protocols outlined in licensing guidelines and conducted in out-patient clinics may not adequately reflect or predict on-road driving performance. The present study undertakes a scoping review of the VF of individuals with an IRD and their driving status and/or performance. It aims to determine the proportion of individuals who either meet the VF licensing requirements or pass a driving test and the impact of VF extent. Methods and analysis 193 publications from online databases and other sources were identified, of which three publications met the inclusion criteria for the review. Publications were from two countries and included studies which measured driving performance based on collision records and driving simulator performance. Results Only level 4 evidence was available on the topic, including two case-control studies and one cross-sectional study. Conclusion One study reported 36% of retinitis pigmentosa patients met the VF licencing requirements. There was inconclusive evidence regarding the impact of VF extent on driving performance, with one study finding that VF extent was predictive of driving performance, and other findings did not correlate.
dlvr.it
September 16, 2026 at 11:23 AM
#ICYMI: Dr. Brian Ballios, Clinician Scientist @dkjei-uhn.bsky.social, was recently featured on The Retina Channel podcast, discussing the latest advances in inherited retinal diseases (IRDs).

Listen to the full episode >> bit.ly/4iuq2KF
@uhn.ca @uhnresearch.ca @kbi-uhn.bsky.social
September 14, 2026 at 8:02 PM
gob irds baby
September 13, 2026 at 2:48 PM
gob irds!
September 13, 2026 at 2:53 PM
The b irds are attacking the moving car. Maybe one of them will finally freak out a little bit. #cultshelf
September 12, 2026 at 6:13 AM
🔬 New research: “mRNA delivery to the retina restores REP1 function in choroideremia” explores a promising non-viral approach to gene augmentation for CHM.

CRF is proud to have supported this research in part.

Read the publication: pmc.ncbi.nlm.nih.gov/articles/PMC...
mRNA delivery to the retina restores REP1 function in choroideremia
Inherited retinal diseases (IRDs) represent a major cause of blindness, yet current viral vector-based gene therapies are limited by high cost, restricted cargo capacity, and safety concerns related t...
pmc.ncbi.nlm.nih.gov
September 11, 2026 at 5:53 PM
#CoffeeCelebs Mel B-irds
September 8, 2026 at 9:43 PM
#DYK: 1 in 1,700 Canadians are living with an IRD.

There is currently no cure for IRDs. But ongoing research in gene and cell therapies offers hope for potential treatments.

Learn more about current IRD research @dkjei-uhn.bsky.social >> ballioslab.com

@uhn.ca @uhnresearch.ca @kbi-uhn.bsky.social
September 8, 2026 at 4:07 PM
What about the fast track favours for NZ donors? Not to mention the huge sums donated to the right to retain neoberalism & tax cuts. Remember IRDs own report said the rich pay 9% in tax vs 22% for the average earner.
Undercover footage verified by Channel 4 News reveals a secret plot by senior Reform UK figures to break the law on party donations. A leading legal expert is now calling for a criminal investigation.

🔗 Read the exclusive story on Substack:
Exclusive: Nigel Farage filmed undercover celebrating secret new foreign donations
Undercover footage verified by Channel 4 News reveals a secret plot by senior Reform UK figures to break the law on party donations. A leading legal expert is now calling for a criminal investigation.
channel4news.substack.com
September 4, 2026 at 2:43 AM
Australians pay more tax and wages are higher. IRDs report on tax said the rich pay half of an ordinary person. Explain that Mike.
September 2, 2026 at 4:24 AM
Ophthopedia Update: Voretigene Neparvovec (Luxturna) for Biallelic RPE65–Associated Retinal Dystrophy: Systematic Review: Biallelic RPE65-associated inherited retinal disorders (IRDs) cause progressive vision loss, impaired light sensitivity, and reduced… #Ophthalmology #Ophthotwitter #Scicomm
Voretigene Neparvovec (Luxturna) for Biallelic RPE65–Associated Retinal Dystrophy: Systematic Review
Biallelic RPE65-associated inherited retinal disorders (IRDs) cause progressive vision loss, impaired light sensitivity, and reduced mobility. Voretigene neparvovec-rzyl (LUXTURNA), the first FDA-approved gene therapy for this condition, is a disease-modifying option whose clinical benefits and harms warrant synthesis.
dlvr.it
August 31, 2026 at 6:46 PM
"Moore's Law" is five different curves that died separately: Dennard scaling failed ~2005-2007. Density per mm² is still rising but slowing, and after ~2031 the IRDS roadmap expects gains from stacking chips, not shrinking transistors. If your roadmap bets on chips getting smaller, it won't hold.
August 28, 2026 at 9:13 PM
Gob irds
July 22, 2026 at 3:57 PM